metotreksat ebewe 10 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 10 mg / 1 ml - metotreksat
metotreksat ebewe 10 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 10 mg / 1 ml - metotreksat
metotreksat ebewe 2,5 mg tablete
ebewe pharma - metotreksat - tableta - metotreksat 2,5 mg / 1 tableta - metotreksat
metotreksat ebewe 5 mg tablete
ebewe pharma - metotreksat - tableta - metotreksat 5 mg / 1 tableta - metotreksat
metotreksat ebewe 10 mg tablete
ebewe pharma - metotreksat - tableta - metotreksat 10 mg / 1 tableta - metotreksat
metotreksat ebewe 10 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 10 mg / 1 ml - metotreksat
nordimet
nordic group b.v. - metotreksat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastična sredstva - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
voraxaze
serb sas - glucarpidase - metabolic side effects of drugs and substances - vsi drugi terapevtski izdelki - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.
metoject 50 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
medac gmbh - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 50 mg / 1 ml - metotreksat
metoject 50 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
medac gmbh - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 50 mg / 1 ml - metotreksat